The Founder of GenScan AI, Ms Mary-Brenda Akoda has referred to as for elevated funding and institutional assist to facilitate adoption of improvements.
Akoda, an Artificial Intelligence (AI) analysis scientist, made the decision throughout a information briefing on Sunday in Lagos.
She received the 2026 Nigeria Prize for Science and Innovation, 100,000 {dollars} prize cash sponsored by Nigeria Liquefied Natural Gas Ltd. (NLNG).
The scientist expressed concern that Nigerian sufferers may miss out on the advantages of homegrown medical know-how, if funding and institutional assist have been inadequate to facilitate its adoption domestically.
She stated that entry to worldwide funding and collaboration with healthcare establishments was vital to finishing scientific validation and securing regulatory approval for GenMRI, her new innovation.
Akoda stated that the brand new invention was able to lowering Magnetic Resonance Imaging (MRI) scan time by as much as 90 per cent.
She stated that this may assist to speed up the scientific adoption of her AI-powered medical imaging know-how in Nigeria.
Akoda stated that her instant problem was transferring the know-how from profitable analysis validation to sensible deployment in hospitals, a course of requiring substantial funding in scientific trials and regulatory compliance.
She recognized worldwide funding establishments, together with the Gates Foundation, Development Innovation Ventures Fund and Global Innovation Fund, as potential companions whose assist may assist speed up the method.
“We find ourselves constrained by having to first deploy elsewhere and then have our own home country, Nigeria, as an afterthought.
“There is the need for partners willing to support clinical adoption in Nigeria,” Akoda stated.
She disclosed that the Ministry of Education had directed that scientific pilots be facilitated, whereas discussions have been ongoing with related healthcare stakeholders to advance the method.
The researcher stated that she was working with scientific companions in Nigeria, the United Kingdom, the United States and Kenya to broaden GenScan’s validation throughout completely different physique areas and scientific settings.
According to her, the innovation has been validated utilizing greater than 8,800 MRI photos and achieved as much as 99.7 per cent similarity to standard MRI photos.
She revealed that an early blinded evaluation by a marketing consultant radiologist at Buckinghamshire Healthcare NHS Trust within the United Kingdom additionally discovered the pictures diagnostically equal to standard scans in all circumstances assessed.
Akoda, nevertheless, emphasised that additional scientific research and regulatory approvals have been crucial earlier than the know-how may very well be deployed for routine scientific use.
She stated that GenMRI was designed to assist hospitals study extra sufferers utilizing present MRI scanners, lowering ready instances and the necessity for pricey investments in extra tools.
According to her, high-quality MRI scanners can price between $1.5 million and $3.5 million or extra.
She stated that the price made it troublesome for healthcare amenities to develop their diagnostic capability by way of tools purchases.
Beyond the know-how’s technical capabilities, Akoda stated that her broader ambition was to bridge the hole between medical analysis and the individuals who want its advantages.
“I don’t believe that innovations should remain on paper. The whole idea of a healthcare innovation is that it eventually transforms the lives of the people who need it most,” she stated.
Akoda stated that her imaginative and prescient for GenScan AI was to make sure that nobody suffered or died due to delayed prognosis.
She attributed her motivation to a private expertise involving the loss of life of an aged cherished one following a stroke, which uncovered the possibly devastating penalties of delays in medical prognosis.
Akoda stated that the expertise prompted her to analyze how AI may assist healthcare professionals overcome systemic challenges and enhance diagnostic effectivity.
The researcher additionally referred to as for stronger collaboration between AI scientists and clinicians, saying that medical applied sciences should be developed round precise healthcare wants fairly than in isolation.
Akoda stated that her goal was to deploy GenMRI within the second half of 2027, topic to funding, scientific validation and regulatory approval.
She urged authorities establishments, healthcare suppliers and worldwide growth companions to assist efforts to deliver the know-how to Nigerian hospitals, noting that its final worth would rely on its accessibility to sufferers. (NAN)(NAN)
Edited by Florence Onuegbu
